Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records.

Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records. Abstract Text:

Noboru Kitamura,Yasuo Takahashi,Shuukoh Yamadate,Satoshi Asai,Noboru Kitamura,Yasuo Takahashi,Shuukoh Yamadate,Satoshi Asai,Noboru Kitamura,Yasuo Takahashi,Shuukoh Yamadate,Satoshi Asai,Noboru Kitamura,Yasuo Takahashi,Shuukoh Yamadate,Satoshi Asai,

ABSTRACT: BACKGROUND: A beneficial effect on glucose metabolism is reported with angiotensin receptor blocker (ARB) treatment of hypertension. The effect on blood glucose level during the course of treatment with ARBs in clinical cases is uncertain. Our objectives were to survey the changes in glucose and HbA1c levels in patients with hypertension over a one-year period, and to study the correlations between these values and the time after the start of ARB therapy. METHODS: We conducted a retrospective longitudinal survey of blood glucose and HbA1c measurements in Japanese patients aged >/=20 years with newly diagnosed hypertension but without diabetes, who had received ARB monotherapy with candesartan cilexetil, losartan potassium, olmesartan medoxomil, telmisartan, or valsartan during the period from December 2004 to November 2005. Data including 2465 measurements of non-fasting blood glucose in 485 patients and 457 measurements of HbA1c in 155 patients were obtained from electronic medical records of Nihon University School of Medicine. Linear mixed effects models were used to analyze the relationship between these longitudinal data of blood examinations and covariates of patient age, sex, medication, and duration of ARB therapy. RESULTS: Casual blood glucose level was associated with the duration of treatment (P < 0.0001), but not with age, sex, or medication. Blood glucose level was significantly decreased during the periods of 0~3 months (P < 0.0001) and 3~6 months (P = 0.0081) compared with baseline, but was not significantly different between 6~12 months and baseline. There was no association between HbA1c level and covariates of sex, age, medication and duration of treatment. CONCLUSION: Our findings provide new clinical evidence that the effects of ARBs on glucose metabolism may change during the course of treatment, suggesting a blood glucose-lowering effect in the short-term after the start of treatment.

Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records. Publishing Authors By Initials

N Kitamura,Y Takahashi,S Yamadate,S Asai,N Kitamura,Y Takahashi,S Yamadate,S Asai,N Kitamura,Y Takahashi,S Yamadate,S Asai,N Kitamura,Y Takahashi,S Yamadate,S Asai,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cardiovascular diabetology

VOLUME: 6

Page Numbers: 26

Journal Abbreviation:

ISSN: 1475-2840

DAY: 29

MONTH: 09

YEAR: 2007

Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101147637

Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records.

AFFILIATION: Division of Genomic Epidemiology and Clinical Trials, Advanced Medical Research Center, Nihon University School of Medicine, Tokyo, Japan. satoshi@med.nihon-u.ac.jp.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cardiovasc Diabetol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records Related Publications

• AMP nucleosidase from Azotobacter vinelandii. II. Association and dissociation.
• Amphoteric charge distribution at the enzymatic site of 1,N6-ethenoadenosine triphosphate-binding heavy meromyosin determined by dynamic fluorescence quenching.
• Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records.
• Change in the ultraviolet absorption of an adenosine triphosphate analog, beta-napht-yl triphosphate, during its hydrolysis by heavy meromyosin.
• Charge effects on the dynamic quenching of fluorescence of 1,N6-ethenoadenosine oligophosphates by iodide, thallium (I) and acrylamide.
• Constipation: Does it increase morbidity and mortality in critically ill patients?
• Contribution of vision to the stabilization of body sway in patients with spinocerebellar degeneration.
• Cooperative conformational change in F-actin filament induced by the binding of heavy meromyosin.
• Decreased expression of thioredoxin interacting protein mRNA in inflamed colonic mucosa in patients with ulcerative colitis.
• Electric potential at regions near the two specific thiols of heavy meromyosin determined by the fluorescence quenching technique. I. Effect of ATP.
• Extraction and some properties of the proteins, Spastin B, from the spasmoneme of Carchesium polypinum.
• Fluorometric method for estimating the kinetic parameters of beta-naphthyl triphosphate and ATP hydrolysis by acto-heavy meromyosin.
• Glucomannan utilization operon of Bacillus subtilis.
• Herniation of the laryngeal mask airway classic.
• Heterogeneity in enzymatic sites of heavy meromyosin shown by measuring F-actin-inactivated hydrolysis of beta-naphthyl triphosphate.
• Is it ethical to have more than one fee schedule?
• Local migration of myosin in F-actin plus ATP solution on the boundary of a diffusion cell.
• New high performance SAW convolvers used in high bit rate and wideband spread spectrum CDMA communications system.
• Novel nuclear and cytoplasmic proteins detected by anti-Zoothamnium arbuscula (Protozoa) spasmin 1 antibody in mammalian cells are dependent on the cell cycle.
• On the rotational brownian motion of a bacterial idle motor I. Theory of time-dependent fluorescence depolarization.
• Prognostic value of blink test in patients with facial paralysis.
• Propagation characteristics of longitudinal leaky SAW in Al-grating structure.
• Repeat oral dosing of prasugrel, a novel P2Y(12) receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
• Some characteristics of beta-naphthyl triphosphate as a substrate of heavy meromyosin. F-actin-inactivated hydrolysis showing initial burst.
• Structural differences in aqueous dispersions of alpha-tocopheryl acetate and phosphatidylcholine upon varying their molar fractions.
• The Effects Of The Resistance And "balance Ball" Exercise Program For Muscle Strength, Balance And QOL In Community-dwelling Elderly Women: 2290: Board #203 June 1 9:00 AM -10:30 AM.
• The effects of solvent viscosity on the kinetic parameters of myosin and heavy meromyosin ATPase.
• Thin-layer optical cell with light path length shorter than 10 [mgr ]m for absorption and fluorescence measurement of highly absorbent solutions.
• [Alcohol-induced asthma.]
• [New methods of preparing bread.]